Forest/Lipha Campral Clears FDA; Part of Alcoholism Management Program
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA clears acamprosate as alcoholism maintenance therapy. The drug may not be effective in patients who are actively drinking at the start of treatment, the agency says.